Had this ban not come through, Ranbaxy would have launched Diovan and Nexium generic from Toansa facility - that is procured API from Toansa unit and formulated in Ohm Laboratories in the US. But now if it has to depend on a third party for API, then product launches can get delayed by 6-12 months.
first published: Jan 24, 2014 03:32 pm
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty Retreat After Hitting Fresh Highs As Rupee Drops To Record Low| Closing Bell Live
Will Solid Q2 GDP Set The Ball Rolling For Nifty Bulls To Cross 26,300 Decisively?|Opening Bell Live
SOBO to Bandra: Why Only South Mumbai Residents Call Bandra a Downgrade | The Tenant
Live: Nifty registers third straight week of gains, up 2% in November | Closing Bell
